Jazz Pharmaceuticals, a developer of medicines in neurology and psychiatry, filed for IPO Friday. Morgan Stanley and Lehman Brothers are the joint book runners on the deal. Terms have not yet been announced.
Jazz Pharmaceuticals, a developer of medicines in neurology and psychiatry, filed for IPO Friday. Morgan Stanley and Lehman Brothers are the joint book runners on the deal. Terms have not yet been announced.